Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Campath-1H and CellCept Induction for CNI-Free Renal Transplantation
NCT00214266Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Jan 2005
- Primary completion
- Aug 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of alemtuzumab in kidney transplantation, sponsored by University of Wisconsin–Madison. Started Jan 2005; status: completed.
02
Drugs
alemtuzumab
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00214266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00214266.